As a TCF/LEF protein belonging to the HMG box family, TCF7L1 is a major downstream effector of the Wnt signaling pathway and is an embryonic stem cell signature gene whose expression is upregulated in multiple aggressive cancer types, including breast cancer, glioblastoma, and bladder cancer [15,37]. This evidence concerns the gene HNF4A and breast carcinoma.